Creative Medical Technology Holdings, Inc.
CELZ
$2.21
$0.00-0.18%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 6.19% | -17.66% | |||
| Depreciation & Amortization | 1.30% | 0.33% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.75% | -24.05% | |||
| Operating Income | -0.75% | 23.91% | |||
| Income Before Tax | -0.21% | 24.71% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -0.21% | 24.71% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -0.21% | 24.71% | |||
| EBIT | -0.75% | 23.91% | |||
| EBITDA | -0.75% | 24.36% | |||
| EPS Basic | -0.21% | 42.21% | |||
| Normalized Basic EPS | -0.20% | 42.21% | |||
| EPS Diluted | -0.21% | 42.21% | |||
| Normalized Diluted EPS | -0.20% | 42.21% | |||
| Average Basic Shares Outstanding | 0.00% | 30.28% | |||
| Average Diluted Shares Outstanding | 0.00% | 30.28% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||